Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.

Sub-classes under this class:

Class Number	Class Name	Patents
514/236.5	The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)	203
514/236.2	Three or more ring hetero atoms in the additional hetero ring	342

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
5447929	Method of treating joint disorders using hydroxamic derivatives	Sep. 5, 1995
5441960	1-pyrimidinylacetamide human leukocyte elastate inhibitors	Aug. 15, 1995
5441957	Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ	Aug. 15, 1995
5438058	Composition intended to be used for retarding hair loss and for inducing and stimulating hair growth, containing 2-alkyl-4-aminopyrimidine (or 2,4-dialkylpyrimidine) 3-oxide derivatives and ne	Aug. 1, 1995
5418233	Heterobiarly derivatives and pharmaceutical compositions thereof	May. 23, 1995
5418237	Indole derivatives	May. 23, 1995
5413997	Triphenylmethane derivatives	May. 9, 1995
5405846	Treatment of ocular hypertension with a synergistic combination	Apr. 11, 1995
5397781	Pyrimidine derivatives	Mar. 14, 1995
5389635	4- or 5-heterocyclic substituted imadazoles as angiotensin-II antagonists	Feb. 14, 1995
5387600	Treating arteriosclerosis using benzimidazole compositions	Feb. 7, 1995
5384319	Aminoalkylphenyl compounds	Jan. 24, 1995
5382583	Piperazine derivatives	Jan. 17, 1995
5380723	Indole derivatives	Jan. 10, 1995
5378707	Aryl-propyl-amines endowed with antifungal activity	Jan. 3, 1995
5376666	Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl	Dec. 27, 1994
5373006	Combination of derivatives of 1,8-hydroxy and/or acyloxy anthracene or anthrone and of pyrimidine derivatives for inducing and stimulating hair growth and reducing loss thereof	Dec. 13, 1994
5373008	Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents	Dec. 13, 1994
5371086	Aminopyridine compounds	Dec. 6, 1994
5369103	Piperazine derivatives	Nov. 29, 1994
5364849	1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives	Nov. 15, 1994
5362729	Dihydropyridine derivatives useful in antitumor therapy	Nov. 8, 1994
5360804	Multicomponent agent or kit for preparing the sulpho-conjugated form of pyridino, pyrimidino or triazino N-oxide compounds and method of use	Nov. 1, 1994
5358945	Pyrimidine compound and pharmaceutically acceptable salts thereof	Oct. 25, 1994
5358946	Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis	Oct. 25, 1994
5356922	Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates	Oct. 18, 1994
5356893	Benzanilide derivatives	Oct. 18, 1994
5352687	Substituted phenylacetamides	Oct. 4, 1994
5348957	5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents	Sep. 20, 1994
5348955	N,N-diacylpiperazines	Sep. 20, 1994
5348954	Heterocyclic chelating agents	Sep. 20, 1994
5344830	N,N-diacylpiperazine tachykinin antagonists	Sep. 6, 1994
5340822	Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present	Aug. 23, 1994
5340812	Piperazine derivatives	Aug. 23, 1994
5338743	New use of the adenosine antagonist	Aug. 16, 1994
5332742	Renin inhibitors	Jul. 26, 1994
5332732	Thiophene and pyridine antipsychotic agents	Jul. 26, 1994
5328916	Heterocyclic compounds useful for inhibition of renin	Jul. 12, 1994
5326761	Fluid ophthalmic composition based on lipid microparticles containing at least one active principle	Jul. 5, 1994
5318980	Sulphonylbenzyl-substituted imidazoles	Jun. 7, 1994
5314887	2-amino-1, 4-dihydropyridine derivatives with calcium agonist and alpha.sub. -antagonist activity	May. 24, 1994
5314892	Fungicidal pyrimidinyloxyphenyl-3-methoxy propenoates	May. 24, 1994
5304555	Pyrimidines and pharmaceutically acceptable salts thereof useful in treatment of neurological disorders	Apr. 19, 1994
5302610	Renal-selective biphenylmethyl imidazole angiotensin II antagonists for treatment of hypertension	Apr. 12, 1994
5292726	N,N-diacylpiperazines	Mar. 8, 1994
5292736	Morpholinoalkylindenes as antiglaucoma agents	Mar. 8, 1994
5292740	Sulfonamides	Mar. 8, 1994
5286728	Amino-substituted piperazine derivatives	Feb. 15, 1994
5264440	Fungicides	Nov. 23, 1993
5262415	Aminopyridine compounds	Nov. 16, 1993